macérat glycériné concentré sommeil
Food supplement declared in France, declaration No 2023-9-1030, decision dated 19 September 2023
macérat glycériné concentré sommeil, from Monsieur Bousquet Michael, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Crataegus laevigata 0.1875 ml per day, Corylus avellana 0.1875 ml per day, Tilia tomentosa 0.1875 ml per day, Ulmus glabra 0.1875 ml per day. None of the rules we check flags an issue with its declared composition.
- Brand
- not provided
- Food business operator placing the product on the market
- Monsieur Bousquet Michael
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Dropper
- Daily dose
- 15 gouttes
- Not recommended (according to the manufacturer)
- Children (under 12), Young children (aged 1 to 3), Infants (under 1 year)
- Objectives stated by the manufacturer (these are not authorised claims)
- Sleep
Declaration 134965, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Crataegus laevigata (Poir.) DC. | Bourgeon | Autre macérât | 0.1875 ml |
| Corylus avellana L. | Bourgeon | Autre macérât | 0.1875 ml |
| Tilia tomentosa Moench | Bourgeon | Autre macérât | 0.1875 ml |
| Ulmus glabra Huds. | Bourgeon | Autre macérât | 0.1875 ml |
Additives
E422
Other ingredients
Alcool éthylique, Eau purifiée
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Crataegus laevigata (Poir.) DC.
Read the warning, when it applies and the studies cited
Hawthorn
Route of administration: Oral (ESCOP 2009; Bradley 2006; Mills and Bone 2000)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking cardiac glycosides (e.g., digoxin) or blood pressure or heart medications (Brinker 2010; Bradley 2006).
Sources cited by Health Canada (2)
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (GB): British Herbal Medicine Association; 2006.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have chest pain, irregular heartbeat, or shortness of breath.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “macérat glycériné concentré sommeil: composition and regulation”, https://compoatlas.com/en/supplements/products/134965-macerat-glycerine-concentre-sommeil, updated 15 November 2026.